Caseflicks

District Court, S.D. New York • 1995

Reuben H. Donnelley Corp. v. Mark I Marketing Corp.

893 F. Supp. 285 | 1995 U.S. Dist. LEXIS 10685

Full access

Unlock the video and quiz

The written brief is free to read below. Subscribe to watch the video explainer and take the quiz.

Create an account Log in

Takeaway

In short, this case shows that a commercial licensing dispute remains a contract case unless the pleading alleges an independent tort, properly performed contractual obligations, or facts establishing a genuinely equitable need for an injunction.

Background

Wallace Edwards developed the Markolor printing process, which uses two opaque inks on colored paper to create a full-color or near-full-color image. Edwards obtained Canadian and U.S. patents for the process and assigned the U.S. patent to Mark I. Mark I-A, an affiliate of Mark I, granted Reuben H. Donnelley Corporation (RHD) an exclusive, renewable license to market and use Markolor. In exchange, RHD agreed to pay licensing fees and royalties and to use its best efforts to promote sales of the process.

RHD later began using and marketing what it called a different “Four Color Process.” Mark I and Mark I-A maintained that this process was really Markolor and demanded royalties. RHD sued for declarations that it did not infringe the U.S. patent, that the patent was invalid, that it had not breached the license agreement, and that it owed no royalties. It also sought repayment of royalties it alleged were mistakenly paid.

Defendants counterclaimed for an accounting, breach of contract based on unpaid royalties and failure to use best efforts, fraud based on RHD’s alleged concealment of its use of Markolor, and a permanent injunction barring RHD from using Markolor. They also sought punitive damages and attorney’s fees. RHD moved under Rule 12(b)(6) to dismiss the fraud, contract, and injunction counterclaims. Defendants initially cross-moved to dismiss RHD’s patent declaratory-judgment claims, but withdrew that motion.

Issues

Issue #1

Whether defendants stated an independent claim for fraud based on RHD’s alleged concealment of its use of the Markolor process to avoid contractual royalty payments.

Holding

No. The alleged concealment was inseparable from the claimed breach of the licensing agreement and did not support either constructive fraud or ordinary fraud under New York law.

Reasoning

New York fraud requires a materially false misrepresentation, knowledge of falsity, an intent to induce reliance, justifiable reliance, and resulting injury. But a party cannot convert an ordinary contract claim into a tort claim merely by characterizing nonperformance as fraud. Where the alleged wrongdoing is not separate and distinct from a failure to perform contractual duties, the claim sounds in contract rather than tort.

Defendants could not establish constructive fraud because the arms-length licensor-licensee relationship between Mark I-A and RHD was not fiduciary. A fiduciary duty arises from a relationship of special trust, confidence, control, or responsibility, not simply from contractual promises. The duties defendants identified—paying royalties and using best efforts to promote Markolor—arose solely from the agreement itself.

The asserted ordinary fraud theory failed for the same reason. Allegations that RHD concealed its contractual breach or misled defendants about its performance did not create an independent fraud claim. Defendants also sought no fraud damages distinct from the losses caused by the alleged breach. The court therefore dismissed the fraud counterclaim as redundant of the contract claims and insufficient to state a separate tort claim.

Issue #2

Whether defendants adequately pleaded their own performance of the licensing agreement in asserting breach-of-contract counterclaims.

Holding

Not fully, but dismissal was denied on the condition that defendants amend within thirty days to allege due performance of their contractual obligations.

Reasoning

Under New York law, a breach-of-contract claim requires an agreement, the claimant’s performance, the opposing party’s breach, and resulting damages. Federal notice pleading does not require each element to be pleaded mechanically, but a claim on an express contract must include some allegation that the claimant performed its own obligations.

The counterclaims alleged facts suggesting that defendants granted RHD an exclusive license: they asserted that RHD received and used an exclusive license and that defendants were prevented from marketing the process to others. Those allegations supported an inference that a license had been provided.

Nevertheless, defendants did not allege that granting the license was their only obligation or that Mark I-A had performed all obligations necessary to demand RHD’s performance. Rather than dismiss the contract counterclaims outright, the court applied the federal rules’ instruction to construe pleadings to achieve substantial justice and gave defendants thirty days to cure the omission by amendment.

Issue #3

Whether defendants could recover punitive or exemplary damages on their contract counterclaim based on RHD’s alleged bad faith and fraud.

Holding

No. The pleaded conduct did not state an independent tort or rise to the exceptional level of moral culpability required for punitive damages in a New York contract dispute.

Reasoning

Punitive damages are ordinarily unavailable for breach of contract under New York law. The New York Court of Appeals’ Rocanova framework requires conduct that is independently actionable as a tort and sufficiently egregious—traditionally involving a public wrong and a high degree of moral turpitude—to justify punishment and deterrence beyond compensatory relief.

The court noted uncertainty in lower-court decisions suggesting that particularly dishonest bad faith in a private contract dispute might sometimes support punitive damages without conduct directed at the public. It did not need to resolve that doctrinal question because defendants’ allegations failed even under the more permissive formulations.

RHD allegedly denied that it was violating the agreement while using a different printing process. Even a deliberate breach, without more, is not the wanton dishonesty or criminal indifference to civil obligations needed for punitive damages. Unlike cases involving efforts to evade court orders or systematically thwart a party’s rights, RHD invoked the court’s jurisdiction to obtain a declaration of its contractual obligations. The court dismissed the demand for punitive and exemplary damages and dismissed any fraud theory embedded in the third counterclaim.

Issue #4

Whether defendants stated a claim for a permanent injunction barring RHD from using the Markolor process.

Holding

No. The counterclaim did not identify a valid substantive basis for injunctive relief or plead irreparable harm and a properly tailored remedy, though defendants were granted leave to amend.

Reasoning

An injunction is a remedy, not an independent cause of action. A party seeking one must allege wrongful conduct supporting equitable relief, irreparable injury for which money damages are inadequate, and equities favoring the requested order.

The alleged wrongdoing was RHD’s breach of the licensing agreement, including nonpayment of royalties, refusal to permit an accounting, and failure to use best efforts to market Markolor. Money damages would plainly compensate for unpaid royalties and could potentially compensate for the claimed failure to promote the process. Defendants did not explain why those legal remedies were inadequate.

The requested permanent ban on RHD’s use of Markolor was also not tailored to remedy the pleaded contractual breaches. It would effectively revoke RHD’s license and prohibit future use, even though defendants had not alleged that the agreement had been legally terminated or that RHD’s post-termination use would infringe Mark I’s patent. The court dismissed the injunction counterclaim but allowed defendants thirty days to amend if they could allege a legal basis—such as valid termination of the license and resulting patent rights—for equitable relief.